688197 fundamentals
Key facts
Shouyao Holdings (Beijing) Co. Ltd. engages in the clinical research stage of the innovative drug business. The company is mainly involved in the research and development of drugs covering non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, thyroid cancer, ovarian cancer, leukemia, key tumor indications, and type 2 diabetes. It offers a collection of AI drug design, medicinal chemistry, biology, pharmacokinetics, toxicology, pharmaceutical research, clinical research, operation management, and quality management. The company was founded on April 19, 2016 and is headquartered in Beijing, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company